Skip to main content
All lobbying filings

ACCENDRA HEALTH INC.

ACCENDRA HEALTH INC. filed a Q4 report for ACCENDRA HEALTH INC. on January 19, 2026.

Lobbying for ACCENDRA HEALTH INC.

All filings by ACCENDRA HEALTH INC. · Everything ACCENDRA HEALTH INC. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 19, 2026
Expenses
$240,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5
Health Issues

Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.

Medicare/Medicaid

Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.

Trade (domestic/foreign)

Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.

Budget/Appropriations

FY 2026 Appropriations.

Veterans

CHAMPVA medical supply reimbursement.

 Bills named in this filing 4

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem